Julian Baker’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Julian Baker’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-800	Closed	-$32K	–	124
2022 Q2	$32K	Sell	800 -10,965	-93%	-$679K	﹤0.01%	117
2022 Q1	$1.24M	Hold	11,765	–	–	0.01%	105
2021 Q4	$1.36M	Hold	11,765	–	–	0.01%	112
2021 Q3	$4.45M	Hold	11,765	–	–	0.02%	100
2021 Q2	$4.8M	Hold	11,765	–	–	0.02%	98
2021 Q1	$5.61M	Buy	+11,765	New	+$6.4M	0.02%	89

Other funds holding NEXI

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allen Operations New York $722M AUM 20.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

KHCM

Kettle Hill Capital Management New York $406M AUM 18.06% 1-Year Est. Return

Julian Baker's NEXI Position: Q3 2022 in Review

Julian Baker sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2022, closing a stake of 800 shares — an estimated $32K sold.

Julian Baker first reported a position in NEXI in Q1 2021 and held it in 6 quarters. The position peaked at $5.61M in Q1 2021. 38 funds tracked by Wall St. Rank hold NEXI as of Q3 2022.

Julian Baker reported no remaining NexImmune, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Julian Baker sold 800 NexImmune, Inc. Common Stock shares in Q3 2022, an estimated $32K.
Julian Baker first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
Julian Baker's NexImmune, Inc. Common Stock position peaked at $5.61M in Q1 2021.
38 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2022.

Based on Baker Bros. Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.